André Delacourte

Active 1980–2010

70
Papers
21,194
Citations
69
h-index
70
i10-index

Citations

Citations per year for André Delacourte1949: 1 citations1971: 1 citations1977: 1 citations1981: 3 citations1982: 8 citations1983: 2 citations1984: 4 citations1985: 1 citations1986: 2 citations1987: 4 citations1988: 4 citations1989: 9 citations1990: 7 citations1991: 26 citations1992: 29 citations1993: 23 citations1994: 55 citations1995: 62 citations1996: 44 citations1997: 94 citations1998: 99 citations1999: 92 citations2000: 128 citations2001: 130 citations2002: 151 citations2003: 141 citations2004: 197 citations2005: 186 citations2006: 212 citations2007: 200 citations2008: 248 citations2009: 289 citations2010: 337 citations2011: 404 citations2012: 361 citations2013: 339 citations2014: 350 citations2015: 286 citations2016: 294 citations2017: 276 citations2018: 200 citations2019: 560 citations2020: 545 citations2021: 503 citations2022: 331 citations2023: 319 citations2024: 369 citations2025: 159 citations2026: 4 citations1950–1970: no citations, so these years are not shown1972–1976: no citations, so these years are not shown1978–1980: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,753 citing papers, 26% of this breakdownUnited Kingdom: 884 citing papers, 8.4% of this breakdownFrance: 682 citing papers, 6.5% of this breakdownChina: 647 citing papers, 6.1% of this breakdownGermany: 626 citing papers, 5.9% of this breakdownItaly: 516 citing papers, 4.9% of this breakdownCanada: 410 citing papers, 3.9% of this breakdownSpain: 373 citing papers, 3.5% of this breakdownAustralia: 336 citing papers, 3.2% of this breakdownSweden: 319 citing papers, 3% of this breakdownNetherlands: 295 citing papers, 2.8% of this breakdownJapan: 283 citing papers, 2.7% of this breakdown
0%26%Other 23.1%

Fields

  • Medicine63.3%
  • Biochemistry, Genetics and Molecular Biology20.1%
  • Neuroscience12%
  • Computer Science1.1%
  • Nursing0.6%
  • Psychology0.4%
  • Other2.5%

Topics

  • Alzheimer's disease research and treatments19%
  • Dementia and Cognitive Impairment Research8%
  • Cholinesterase and Neurodegenerative Diseases3.1%
  • Neuroinflammation and Neurodegeneration Mechanisms2.8%
  • Neuroscience and Neuropharmacology Research2.8%
  • Parkinson's Disease Mechanisms and Treatments2.5%
  • Other61.8%

Coauthors

All papers

Open in search
  1. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria

    Authors: , , , , , , , , , , , , , , , , , , - The Lancet Neurology 2007 cited by 4,384

  2. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders11These authors contributed equally to this work.

    Authors: , , , , - Brain Research Reviews 2000 cited by 1,996

  3. Revising the definition of Alzheimer's disease: a new lexicon

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Neurology 2010 cited by 1,850

  4. Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/β-secretase expression

    Authors: , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2008 cited by 1,174

  5. MicroRNA regulation of Alzheimer's Amyloid precursor protein expression

    Authors: , , , , , , - Neurobiology of Disease 2008 cited by 439

  6. Loss of VGLUT1 and VGLUT2 in the prefrontal cortex is correlated with cognitive decline in Alzheimer disease

    Authors: , , , , , , , , , , , - Neurobiology of Aging 2007 cited by 183

  7. Adeno-associated Virus Gene Therapy With Cholesterol 24-Hydroxylase Reduces the Amyloid Pathology Before or After the Onset of Amyloid Plaques in Mouse Models of Alzheimer's Disease

    Authors: , , , , , , , , , , - Molecular Therapy 2009 cited by 195

  8. The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer’s disease

    Authors: , , , , , , , , , , , - Neurology 1999 cited by 809

  9. Apolipoprotein E, ɛ4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region

    Authors: , , , , , , , , , , , , , - Human Molecular Genetics 1994 cited by 435

  10. Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders

    Authors: , , , , , , - Acta Neuropathologica 1994 cited by 329

  11. Neurosteroid Quantification in Human Brain Regions: Comparison between Alzheimer’s and Nondemented Patients

    Authors: , , , , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2002 cited by 326

  12. Differential distribution of neurofibrillary tangles in the cerebral cortex of dementia pugilistica and Alzheimer's disease cases

    Authors: , , , , , - Acta Neuropathologica 1992 cited by 214

  13. The Orphan G Protein–Coupled Receptor 3 Modulates Amyloid-Beta Peptide Generation in Neurons

    Authors: , , , , , , , , , , , , , - Science 2009 cited by 196

  14. Biochemistry of Tau in Alzheimer’s disease and related neurological disorders

    Authors: , , , , , , , , , , , - Expert Review of Proteomics 2008 cited by 297

  15. Massive CA1/2 Neuronal Loss with Intraneuronal and N-Terminal Truncated Aβ42 Accumulation in a Novel Alzheimer Transgenic Model

    Authors: , , , , , , , , , , , , , , , , , , , - American Journal Of Pathology 2004 cited by 401

  16. Alzheimer's disease: Tau proteins, the promoting factors of microtubule assembly, are major components of paired helical filaments

    Authors: , - Journal of the Neurological Sciences 1986 cited by 315

  17. Evidence of a balance between phosphorylation and O-GlcNAc glycosylation of Tau proteins—a role in nuclear localization

    Authors: , , , , , , , - Biochimica et Biophysica Acta (BBA) - General Subjects 2003 cited by 201

  18. Brain Microvascular Changes in Alzheimer's Disease and Other Dementiasa

    Authors: , , - Annals of the New York Academy of Sciences 1997 cited by 167

  19. Tau protein as a differential biomarker of tauopathies

    Authors: , , - Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2004 cited by 300

  20. Alkalizing Drugs Induce Accumulation of Amyloid Precursor Protein By-products in Luminal Vesicles of Multivesicular Bodies

    Authors: , , , , , , , , , , - Journal of Biological Chemistry 2007 cited by 191

  21. Pin1 allows for differential Tau dephosphorylation in neuronal cells

    Authors: , , , , , , , , , , , , , , - Molecular and Cellular Neuroscience 2006 cited by 79

  22. Raft disorganization leads to reduced plasmin activity in Alzheimer's disease brains

    Authors: , , , , , , , - EMBO Reports 2003 cited by 130

  23. Loss of somatostatin-like immunoreactivity in the frontal cortex of Alzheimer patients carrying the apolipoprotein epsilon 4 allele

    Authors: , , , , , - Neuroscience Letters 1998 cited by 92

  24. Neuronal membrane cholesterol loss enhances amyloid peptide generation

    Authors: , , , , , , , , - The Journal of Cell Biology 2004 cited by 336